ArticleDigestive diseases and sciences2026

Incidence of Gastrointestinal Adverse Events and Healthcare Resource Utilization in Patients Using Glucagon-Like Peptide-1 Analogs: A Real-World Study.

Piyush Nathani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.